Delivery Order SPE2DB22D3301-SPE2DB25FZ0FD
- Not listed
- This is a $41,217.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ETHACRYNATE SODIUM 50 MG VIALS, a pharmaceutical product, with a final completion date of June 27, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Sodium Phenylacetate-Sodium Benzoate VL 50ML with a ceiling value of $16,121.40 and a firm fixed price structure. The order is due for completion by September 2, 2025, and represents a non-competitive, non-set-aside award executed under the company's existing contract vehicle. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4,987.18 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ephedrine Sulfate 50 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of August 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made without set-aside designation, indicating open competition. Performance will occur at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,288.33 to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and runs through December 2026. The delivery order will be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for EMERPHED 50 mg/10 mL vials with a ceiling value of $1,390.95 and a firm fixed price structure. This non-set-aside competitive award is classified as a delivery order, with ultimate completion scheduled for August 11, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This delivery order, valued at $142,433.37, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, under a firm fixed-price arrangement with an ultimate completion date of July 22, 2025. The contract is executed through the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense responsible for pharmaceutical and medical product distribution to military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,728.21 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,319.33 to AmerisourceBergen Drug Corp for the supply of Sodium Chloride 0.9% vials (10mL) under a firm fixed-price contract. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- This delivery order, valued at $84,183.82, was awarded to AmerisourceBergen Drug Corp on August 11, 2025, under a firm fixed price contract with an ultimate completion date of August 12, 2025. The award represents a non-set-aside, competitively awarded delivery order supporting the Defense Logistics Agency's Medical Supply Chain operations. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0FDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,878.40 to AmerisourceBergen Drug Corp for the supply of Ethacrynate Sodium 50 mg vials. The contract employs firm fixed pricing with a delivery completion deadline of September 2, 2025. This non-competitive, non-set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing comprehensive medical supply solutions to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated substantial capacity to fulfill federal procurement requirements through multiple competitive awards across a wide range of pharmaceutical products and medical commodities. This delivery order for Ethacrynate Sodium, a diuretic medication, represents one of numerous pharmaceutical deliveries executed under the DLA's global pharmaceutical support vehicle, which enables flexible sourcing of branded and generic drugs, vaccines, and specialized medical supplies to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/29/25 |